US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

QTTB

Q32 Bio (QTTB)

Q32 Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:QTTB

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/11	21 : 07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:QTTB	Q32 Bio Inc
2024/12/11	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTTB	Q32 Bio Inc
2024/12/11	06 : 05	PR Newswire (US)	Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program	NASDAQ:QTTB	Q32 Bio Inc
2024/11/07	21 : 28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:QTTB	Q32 Bio Inc
2024/11/07	21 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QTTB	Q32 Bio Inc
2024/11/07	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTTB	Q32 Bio Inc
2024/11/07	20 : 59	PR Newswire (US)	Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:QTTB	Q32 Bio Inc
2024/11/05	20 : 59	PR Newswire (US)	Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference	NASDAQ:QTTB	Q32 Bio Inc
2024/10/17	09 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/10/14	19 : 59	PR Newswire (US)	Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024	NASDAQ:QTTB	Q32 Bio Inc
2024/10/11	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/09/28	10 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/09/28	10 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/09/28	10 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/09/28	10 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/08/29	19 : 59	PR Newswire (US)	Q32 Bio to Participate in Upcoming September Investor Conferences	NASDAQ:QTTB	Q32 Bio Inc
2024/08/15	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTTB	Q32 Bio Inc
2024/08/08	20 : 18	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:QTTB	Q32 Bio Inc
2024/08/08	20 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QTTB	Q32 Bio Inc
2024/08/08	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTTB	Q32 Bio Inc
2024/07/09	20 : 15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:QTTB	Q32 Bio Inc
2024/07/09	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTTB	Q32 Bio Inc
2024/07/09	19 : 59	PR Newswire (US)	Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis	NASDAQ:QTTB	Q32 Bio Inc
2024/07/01	19 : 59	PR Newswire (US)	Q32 Bio Joins Russell 3000® Index	NASDAQ:QTTB	Q32 Bio Inc
2024/06/01	05 : 25	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:QTTB	Q32 Bio Inc
2024/05/09	20 : 26	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:QTTB	Q32 Bio Inc
2024/05/09	20 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QTTB	Q32 Bio Inc
2024/05/09	20 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTTB	Q32 Bio Inc
2024/05/09	19 : 59	PR Newswire (US)	Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:QTTB	Q32 Bio Inc
2024/04/03	20 : 00	PR Newswire (US)	Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer	NASDAQ:QTTB	Q32 Bio Inc

Showing the most relevant articles for your search:NASDAQ:QTTB

1

Gold vs US Dollar

US Dollar vs Euro

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約